Care Shift

Most startups kill their growth by not understanding what really convinces payers, but our guest, Mike Roaldi, has cracked the code. After a decade at UnitedHealth, where he mastered the art of winning enterprise deals, he’s now leading CityBlock’s revolutionary expansion into Medicaid and Medicare at a scale most founders only dream of. This episode reveals the insider secrets to building credibility, demonstrating impact, and sealing those critical partnerships, all rooted in Mike’s deep experience navigating complex health systems.You’ll discover how top health organizations evaluate startups: Why concrete, granular ROI metrics beat vague promises every time. Mike shares the counterintuitive truth about storytelling in pitches: We also dive into the mechanics of navigating multi-layered organizational decisions: Why patience, responsiveness, and organizational cohesion often seal the deal faster than a perfect slide deck. Plus, Mike reveals his approach to transparent performance data, why that builds trust faster, and how AI is embedded everywhere in CityBlock’s model—from risk profiling to direct member engagement.Why does understanding provider diversity and the social determinants of health matter more than ever? Mike’s firsthand stories shed light on designing connected, community-centric care that’s scalable without losing the local touch. And for founders wondering about the long game, he discusses key strategic choices, like hiring industry insiders versus technical geniuses, that can make or break your healthcare venture at scale.This episode is perfect for health entrepreneurs, product teams, and anyone eager to turn initial pilots into sustainable, insurable growth. More on SathvikLinkedIn: www.linkedin.com/in/sathvik-bilakanti-8b5344169X:x.com/sathvikbilCare Shift: https://careshift.vc/Vaelion Ventures: vaelion.vcMore on MikeLinkedIn: https://www.linkedin.com/in/michaelbroaldi/Cityblock Health Website: https://www.cityblock.com/

Explore the transformative role of AI in biotech with Thomas Clozel, co-founder of Owkin. Discover how AI is reshaping drug discovery, personalized medicine, and the future landscape of healthcare.Founded in 2016 by Thomas (a former clinical hematologist) and AI researcher Gilles Wainrib, Owkin pioneered federated learning in healthcare, a technique that lets AI models learn from siloed hospital and biopharma datasets without ever moving the underlying patient data. The result: a platform that turns the world's most sensitive medical data into one of its most powerful research engines.Owkin became a unicorn in November 2021 after a $180M strategic investment from Sanofi, and has raised ~$300M+ in total from investors including Google Ventures, Bpifrance, F-Prime Capital, Eight Roads, and Mubadala. The company partners with leading pharma companies (Sanofi, BMS, Amgen, Roche) and top medical institutions (Mount Sinai, Institut Curie, Léon Bérard) to accelerate drug discovery, optimize clinical trials, and advance precision oncology.Main Insights:AI's Transformative Power: AI is revolutionizing biotech by enhancing the understanding of complex diseases and accelerating drug development.Investment in Innovation: Owkin focuses on leveraging high-quality data and federated learning to drive breakthroughs in medical research.Strategic Integration: Successful AI integration requires collaboration with hospitals and embedding technology into existing workflows.Global Perspectives: The interconnected nature of global healthcare offers valuable lessons in innovation and data sharing.Challenges and Opportunities: Navigating data privacy, regulatory, and societal acceptance issues remains crucial for AI's integration.More on SathvikLinkedIn: www.linkedin.com/in/sathvik-bilakanti-8b5344169X:x.com/sathvikbilCare Shift: https://careshift.vc/Vaelion Ventures: vaelion.vcMore on Thomas Clozel & OwkinLinkedIn: https://www.linkedin.com/in/thomas-clozel-408a9321/X: https://x.com/TClozelOwkin: https://www.owkin.com/

This episode features Joe Cunningham, founding managing director and co-founder of Sante Ventures. We delve into the transformative role of AI in healthcare, exploring investment strategies, innovation, and the future landscape of biotech and medtech. Joe shares insights on how AI is reshaping patient care, investment opportunities, and the challenges and strategies for startups aiming to thrive in this dynamic environment.Main insights: AI's Transformative Power: AI is revolutionizing healthcare by enhancing personalized medicine and streamlining drug development processes.Investment in Innovation: Sante Ventures focuses on investing in groundbreaking biotech and medtech companies that address significant unmet medical needs.Strategic Integration: Successful AI integration requires embedding technology into existing healthcare workflows to enhance efficiency and outcomes.Global Perspectives: The interconnected nature of global healthcare offers valuable lessons in regulatory agility and innovation.Challenges and Opportunities: Navigating regulatory, liability, and societal acceptance issues remains crucial for AI's universal integration.Timestamps:00:00 - Introduction to AI's impact on healthcare investment02:15 - Exploring biotech and medtech innovations05:30 - The role of AI in personalized medicine08:45 - Investment strategies for emerging healthcare technologies12:00 - Overcoming regulatory and societal challenges15:20 - Global perspectives on healthcare innovation18:40 - Building trust and relationships with healthcare providers22:00 - Future trends in healthcare investment and AI25:30 - The importance of strategic partnerships28:45 - Insights on market dynamics and competition32:10 - Preparing for systemic shifts in healthcare delivery35:50 - The role of AI in cost efficiency and economic implications39:15 - Navigating regulatory hurdles and governance considerations42:30 - Structural changes in healthcare delivery46:00 - Final thoughts and wrap-upMore on SathvikLinkedIn: www.linkedin.com/in/sathvik-bilakanti-8b5344169X:x.com/sathvikbilCare Shift: https://careshift.vc/Vaelion Ventures: vaelion.vcMore on Joe CunninghamLinkedIn: https://www.linkedin.com/in/joe-cunningham-4168527/Sante Ventures: https://sante.com/

Future of AI in Healthcare: Patient Engagement, Provider Workflows, and Market DynamicsThis episode features Chirag Shah, a partner at Define Ventures, and Ian Chiang, a partner at Flare Capital Partners. They explore the rapidly evolving landscape of AI in healthcare, focusing on patient engagement, provider workflows, and systemic changes expected over the next five years. With insights from industry experts, we discuss practical applications, challenges, and strategic considerations for startups and established players aiming to innovate responsibly and effectively.Main insights:The pace of AI-driven change in healthcare is unprecedented, making predictability difficult but full of opportunity.AI will significantly empower patients by providing personalized tools that complement or even surpass traditional clinician knowledge in certain areas.The future of care delivery lies in offering diverse modalities, virtual, in-person, asynchronous, and tailored to patient preferences.Specialized AI adoption will vary by field, with radiology highlighted as poised for collaboration rather than replacement.Integration strategies are critical: embedding AI into existing workflows (via EHRs, etc.) is often more feasible than wholesale process overhaul.Distribution, trust, and continual product evolution are key competitive advantages amid crowded markets.Frontier regions like Africa often leap ahead through necessity, offering models for accelerated adoption.Regulatory, liability, and societal acceptance issues remain central hurdles to universal AI integration.The global landscape for healthcare AI is interconnected, with valuable lessons crossing borders, especially regarding regulatory agility.Timestamps:00:00 - Introduction to AI's rapid evolution in healthcare02:04 - Envisioning the ideal patient-provider relationship with AI03:45 - Empowering patients and caregiver dynamics07:42 - The coexistence of virtual and in-person care08:38 - Personalization and broad access to healthcare services09:11 - AI's role in addressing clinician burnout and burnout mitigation10:59 - The emotional and empathetic aspects AI can't replace13:26 - AI's impact on radiology and specialties with workforce shortages15:22 - Improving clinical workflows with AI from pre-visit to post-visit17:39 - Navigating market saturation and competitive differentiation22:32 - Distribution strategies and deep customer engagement26:20 - The challenges of workflow transformation versus integration30:37 - Adoption, regulatory hurdles, and governance considerations36:16 - Contrarian views on value-based care and AI's role40:42 - Preparing for systemic shifts in healthcare payment models44:41 - Structural changes in healthcare delivery and enterprise positioning47:00 - The importance of trust and building relationships with payers and providers48:59 - Margins, cost efficiency, and AI's economic implications55:38 - Global opportunities and international AI adoption dynamics59:19 - Final thoughts and wrap-upMore about Chirag & Define VenturesChirag Shah's LinkedIn: https://www.linkedin.com/in/chiragdefine/Define Ventures LinkedIn: https://www.linkedin.com/company/definevc/Define Ventures Website: about:blankMore about Ian Chiang & Flare Capital PartnersIan Chiang's LinkedIn: https://www.linkedin.com/in/ian-chiang-mba/Ian Chiang's X: https://x.com/IanEChiangFlare Capital Partners LinkedIn: https://www.linkedin.com/company/flare-capital-partners/Flare Capital Partners Website: https://www.flarecapital.com/Sathvik BilakantiSathvik on LinkedIn: www.linkedin.com/in/sathvik-bilakanti-8b5344169Sathvik on X:https://x.com/SathvikBilCare Shift Website: https://careshift.vc/

In this episode, Demetri Giannikopoulos, Chief Innovation Officer of Rad AI, shares deep insights into how AI is revolutionizing radiology and healthcare, tackling workforce shortages, and building trust in AI-driven systems. Whether you're an entrepreneur, healthcare professional, or AI enthusiast, this discussion reveals the critical intersection of technology, policy, and human-centered design transforming healthcare delivery.Show NotesShortage of ER Radiologists & Fellowshipshttps://pubmed.ncbi.nlm.nih.gov/30498926/https://link.springer.com/article/10.1007/s10140-025-02401-x Key Topics Covered:The role of AI as a critical infrastructure for solving the impending physician and nurse shortages by 2030 and beyondHow radiology's mature AI adoption makes it an ideal testing ground for clinical AI solutionsThe importance of AI trust, personalization, and transparency in clinical workflowsStrategies for navigating market competition and establishing ROI with large healthcare systemsRegulatory and compliance considerations, including privacy policies and new policies needed for AI in healthcareThe evolution of Rad AI's product offerings and how they continuously tailor solutions to radiologistsThe impact of AI integration on radiologist burnout and workflow efficiencyThe future pathways for AI in cross-specialty linkage and holistic patient careLeadership lessons from within the industry and how founders can focus on solving real problems, not just building solutionsTimestamps:(00:00) - Introduction to Demetri Giannikopoulos and the show’s focus(02:00) - AI as clinical infrastructure and workforce shortages in healthcare(04:00) - AI's role in addressing physician and nurse shortages by 2030(07:00) - Radiology as the pioneer in clinical AI adoption(09:00) - Receptivity to AI during healthcare policy discussions(11:00) - Embracing AI as an essential tool rather than a replacement(13:00) - The importance of problem-first product development(15:00) - How Rad AI scales and personalizes AI models(17:00) - Market trust through radiologist-driven design(20:00) - Challenges and opportunities with healthcare data privacy and regulation(23:00) - Trust-building through personalized AI impressions(26:00) - How AI reduces radiologist burnout and enhances workflow(30:00) - Future integration of AI across medical specialties(33:00) - The role of continuous iteration and change management(36:00) - How radiology’s unique workflow shapes product design(39:00) - The technology evolution driven by large language models(43:00) - Building scalable, mission-critical AI systems in healthcare(49:00) - Leadership insights from Demetri and the founder’s perspective(54:00) - Market dynamics following industry shifts like Nuance’s exit(1:01:00) - The future of AI and radiology in the next 2-3 years(1:06:00) - Vision for cross-specialty AI linkage and holistic healthcare(1:08:00) - Balancing personal and professional life in health tech leadership(1:10:00) - Final thoughts and key takeawaysDemetri GiannikopolousDemetri's LinkedIn: https://www.linkedin.com/in/dgianniko/Rad AI: https://www.radai.com/Sathvik BilakantiSathvik's LinkedIn: https://www.linkedin.com/in/sathvik-bilakanti-8b5344169/Care Shift: https://careshift.vc/

Discover how Elektra Health is pioneering a new era in women's healthcare by addressing the often-overlooked needs of midlife women. Through innovative telemedicine solutions and strategic insurance partnerships, Elektra Health is breaking down systemic barriers and societal taboos, offering accessible, evidence-based care that empowers women during menopause and beyond. Main Topics We Covered: The untapped potential of menopause and midlife women’s healthSystemic barriers and societal taboos impacting care access, and how Elektra's insurance integration and payer partnerships are changing the landscape. The importance of trust, engagement, and data in building scalable health solutions. Strategies for navigating regulatory hurdles and scaling in a complex environment. Insights on product-market fit, stakeholder education, and investor relationsTimestamps:00:36 - The scope and scale of menopause as a long-term health concern01:34 - Societal barriers, ageism, and the need for innovation in women's health03:23 - The future of women’s healthcare: defragmentation and integrated models04:48 - Models focusing on chronic disease management and holistic support05:39 - How menopause impacts broader health outcomes and aging07:22 - The challenge women face in locating appropriate care and overcoming hesitation08:33 - Socioeconomic disparities and cultural taboos in menopause care10:02 - The impact of the 2002 Women's Health Initiative study on hormone therapy perception11:37 - Revisiting hormone therapy safety and the evolution of treatment options13:01 - Elektra's role in providing evidence-based hormone therapy access14:14 - The importance of comprehensive care, patient-provider conversations, and reimbursement issues15:08 - Partnering with payers, insurance coverage, and expanding access16:21 - Contracting with payers and demonstrating ROI for broader acceptance17:17 - Outcomes data and claims analysis driving payer confidence19:39 - Metrics that gauge patient engagement and satisfaction22:25 - Holistic treatment, family experience, and primary care integration23:42 - Economic costs of untreated menopause symptoms27:18 - Downstream health risks and cost implications of undertreated menopause30:32 - Patient journey to Elektra and personalized care approaches32:48 - Building trust through content, clinical expertise, and transparency34:36 - Engagement with health systems and expanding access in underserved areas37:22 - Early days, lessons learned, and shifting from DTC to enterprise models39:23 - Evolving market awareness, education efforts, and stakeholder engagement41:32 - Partnerships with other women’s health platforms and ensuring coordination43:13 - Navigating compliance, regulations, and high-quality scale45:17 - Building patient trust amidst AI tools and digital health innovation46:16 - The importance of authentic engagement and community-building48:03 - Overcoming initial rejections, misconceptions, and stakeholder education52:26 - Challenges in fundraising for women-led, health tech startups55:02 - The defining moment that sparked Elektra's founding vision56:52 - Lessons and regrets, especially around insurance and market timing58:53 - Differentiating Elektra in a crowded market with evidence-based, insurance-covered care59:46 - Patient pathways, recurring visits, and insurance coverage61:12 - Vision for the future: integrated, proactive menopause care in health systems62:37 - Non-obvious first steps for entrepreneurs: following the money and demonstrating value64:38 - How health systems can prioritize partnerships with startups66:22 - Balancing entrepreneurship and personal life—rejecting perfect balance for ongoing juggleJannine VersiLinkedIn: https://www.linkedin.com/in/jversi/Elektra Health: https://www.elektrahealth.com/Care Shift: https://careshift.vc/Sathvik Bilakanti: https://www.linkedin.com/in/sathvik-bilakanti-8b5344169/Sathvik on X: x.com/sathvikbil

What if the biggest opportunities in healthcare are hiding in the hardest, most overlooked areas?In this episode, Jay Fraser, Managing Partner at Side Door Ventures, breaks down why data tooling, cell systems, neurodegeneration, and advanced diagnostics are poised to drive the next wave of breakthroughs—despite long sales cycles and regulatory complexity.We explore how AI-driven data, cellular modeling, and high-density datasets are reshaping drug discovery and personalized medicine, and why these “unsexy” categories may produce the most venture-scale outcomes.You’ll learn:• Which overlooked sectors are quietly becoming massive opportunities• Why data quality and density are becoming biotech’s biggest advantage• What investors look for in founders tackling high-friction, high-reward marketsTimestamps0:00 - Introduction by Sathvik Bilakanti, introducing Jay Fraser and the focus of the episode.0:07 - Jay Fraser expresses excitement for the conversation.0:12 - Discussion on Side Door Ventures' focus on healthcare and biotech.0:29 - Jay Fraser talks about the challenges and opportunities in healthcare investment.0:57 - Exploration of data acquisition and tooling in biotech.1:24 - Discussion on the importance of data in biotech and pharma.1:54 - Jay Fraser explains the potential in biotech data providers.2:24 - Opportunities in protein and RNA space.2:53 - Importance of data density in biotech.3:23 - Discussion on cell systems and data generation.3:52 - Jay Fraser talks about genetic code and cellular changes.4:21 - Importance of understanding cellular systems in drug discovery.4:50 - Jay Fraser shares his interest in diagnostics.5:18 - Challenges and innovations in diagnostics.5:48 - Interest in neurodegeneration and system-level problems.6:18 - Discussion on clinical diagnostics and opportunities.7:11 - Jay Fraser talks about vocal biomarkers and clinical decision support.8:09 - Importance of data in clinical decision support.9:23 - Discussion on AI's role in healthcare and skepticism about replacing physicians.10:28 - Jay Fraser talks about the future of AI in healthcare.11:23 - Discussion on the supportive role of AI in healthcare.12:43 - Jay Fraser discusses tools helping physicians with AI.13:37 - Importance of clinical decision support in oncology.14:35 - Discussion on the order of treatment in oncology.15:04 - Jay Fraser talks about pattern matching in clinical decision support.16:18 - Discussion on financial incentives for startups in healthcare.17:14 - Importance of understanding revenue and efficiency in healthcare startups.19:44 - Jay Fraser shares his journey into venture capital and entrepreneurship.21:59 - Lessons learned from investing and entrepreneurship.24:06 - Discussion on the importance of pattern matching in investing.25:43 - How Side Door Ventures helps companies from seed to series A.27:31 - Challenges of fundraising for startups.29:51 - Importance of storytelling in fundraising.32:30 - Misunderstandings about fundraising and deal pricing.35:28 - Discussion on valuations in healthcare sectors.37:38 - Jay Fraser shares an investment they passed on.41:17 - Timeline from first pitch to investment decision.43:03 - Jay Fraser's personal interest in healthcare.46:13 - Sectors in healthcare ripe for venture-scale disruption.50:55 - Discussion on data needed for longevity companies.54:09 - Recommendations for selling to clinics and health systems.56:00 - Benefits of working with Side Door Ventures.57:21 - Interest in neurodegeneration and diagnostics.61:14 - Importance of preventative medicine and patient education.63:06 - Rapid-fire questions and closing remarks.Jay FraserLinkedIn: https://www.linkedin.com/in/fraserjay/Side Door Ventures: https://www.sdv.vc/Sathvik BilakantiLinkedIn: https://www.linkedin.com/in/sathvik-bilakanti-8b5344169/Care Shift: https://careshift.vc/

In this episode, Eric Kinariwala, founder and CEO of Capsule, shares how his company is disrupting the traditional pharmacy model through innovative technology, AI, and customer-centric strategies. Discover how Capsule is reducing friction in healthcare, improving medication adherence, and reshaping the future of pharmacy.Main insights include:The genesis of Capsule from frustration with outdated pharmacy systems and how personal experience drove its missionThe evolution of pharmacy technology over the last decade and the shift towards a digital-first modelHow Capsule’s business model leverages modern technology to eliminate common pharmacy pain points like stockouts, long wait times, and billing complexityThe role of AI in automating workflows, personalizing patient experiences, and expanding access to careThe importance of trust, consistency, and stakeholder collaboration in building a successful healthcare platformFuture trends in pharmacy: policy changes, AI adoption, and the potential for automation in last-mile logistics like drone deliveryCapsuleWebsite: https://www.capsule.com/Eric KinariwalaEric's Linkedin: https://www.linkedin.com/in/ekinariwala/Care ShiftWebsite: https://careshift.vc/Care Shift LinkedIn: https://www.linkedin.com/company/care-shift/?viewAsMember=trueSathvik BilakantiSathvik's LinkedIn: www.linkedin.com/in/sathvik-bilakanti-8b5344169

Join us as we explore the landscape of AI in healthcare with Chetan Reddy, CEO of Confido Health. Discover how AI voice agents are transforming healthcare operations, the strategic value of capacity enhancement, and the dynamics of healthcare tech adoption.Chetan shares insights on:The market landscape and total addressable marketGo-to-market dynamics from SMB to enterpriseValue proposition and ROI narrativeRevenue impact and long-term financial benefits for clinicsAdoption, change management, and deployment velocityTechnology choices and model strategyPatient engagement and channel strategyDemographics, specialties, and outreach focusCustomer acquisition, retention, and founder-led salesCompetitive positioning, partnerships, and platform strategyInvestor perspective and capital strategyRejections, resilience, and early milestonesMoat, long-term differentiation, and product-market fitQuick-fire reflections and founder-life balanceTimestamps00:00 Intro00:34 Market landscape and total addressable market02:51 From SMB to enterprise: go-to-market dynamics05:01 Value proposition and ROI narrative07:30 Revenue impact and long-term financial impact for clinics09:46 Adoption, change management, and deployment velocity14:57 Technology choices and model strategy16:18 Demographics, specialties, and outreach focus28:13 Competitive positioning, partnerships, and platform strategy33:12 Patient engagement and channel strategy35:57 Customer acquisition, retention, and founder-led sales44:26 Investor perspective and capital strategy52:13 Rejections, resilience, and early milestones54:22 Moat, long-term differentiation, and product-market fit57:02 Quick-fire reflections and founder-life balanceConfido Health InfoWebsite: https://www.confido.health/Chetan's LinkedIn: https://www.linkedin.com/in/mchetanreddy500/Chetan's X: https://x.com/mchetanreddy500Confido Health Linkedin: linkedin.com/company/confido-health/Care ShiftCare Shift Website: https://careshift.vc/Care Shift LinkedIn: https://www.linkedin.com/company/care-shift/?viewAsMember=trueSathvik's LinkedIn: www.linkedin.com/in/sathvik-bilakanti-8b5344169Sathvik's X: https://x.com/SathvikBil

clinical background shapes his investment strategies, the importance of niche expertise, and the dynamics of healthcare tech investments.Nadav shares insights on: The conservative nature of healthcare and its impact on innovation Differentiating between platform and niche investments The significance of listening to market signals and rapid learning Navigating the complexities of healthcare buyers and procurement The strategic value of a smaller, focused fundTimestamps00:00 Intro 00:22 Nadav's Journey from Clinical Work to VC 06:02 Skills Transfer from Medicine to VC12:37 Market Observations and Skepticism 14:16 Importance of Listening to Market Signals 21:51 The $40M Fund Strategy 24:14 Growth Pace vs. Realistic Trajectories 28:29 Deal-Making Discipline and Signals 32:45 Regulatory Realities in Healthcare Tech 36:50 Understanding Healthcare Buyers 43:29 Sourcing, Partnerships, and Value Add 46:38 The Role of Sales in Founders 48:00 Final Notes and Wrap-UpFollow Nadav on LinkedIn:   / nadav-shimoni-md  A-Squared Ventures Website: https://asquared.arkin-capital.com/Care ShiftFollow Care Shift on LinkedIn: https://www.linkedin.com/company/care...Care Shift on X: https://x.com/careshiftvcSathvik BilakantiSathvik on X: https://x.com/SathvikBilSathvik on LinkedIn: www.linkedin.com/in/sathvik-bilakanti-8b5344169

Most breakthroughs in healthcare will come from proprietary data, yet most startups overlook this crucial moat. In this eye-opening episode, Doug Nissenoff, founder of Intelligence Ventures, reveals why data dominance is the real game-changer in AI-powered healthcare. He breaks down how the biggest wins are often about unique partnerships, niche datasets, and relentless hustle, not just technology alone.Discover why clinical manufacturing processes remain underserved, despite AI's promise, and how secret weapons like blood biomarkers and EKG analytics create unfair advantages that investors crave. Doug shares concrete examples from his portfolio, diagnostics companies capturing unseen data and founders with deep institutional ties who can unlock a universe of high-value partnerships. He explains how proprietary data, not just algorithms, separates the contenders from the pretenders.You'll learn why today’s headlines about ChatGPT and quantum computing are just the tip of the iceberg. Doug discusses the long horizon for biotech, the importance of founder hunger over credentials, and how early-stage investors can identify non-obvious opportunities before they become crowded. He emphasizes community-building, strategic partnerships, and quick iteration as keys to venture success.Essential listening for founders, investors, and anyone looking to understand where healthcare innovation is headed. This episode arms you with the insight to find overlooked spaces, forge invaluable alliances, and build defensible moats in an increasingly competitive landscape. If you’re aiming to win at the intersection of AI and healthcare, this is your blueprint.Doug Nissinoff is managing partner at Intelligence Ventures, a venture capital firm investing in early-stage AI healthcare startups. Known for spotting high-impact niche opportunities, Doug’s expertise lies in proprietary data strategies and industry relationships that accelerate startup growth and exits.TImestamps00:00 Introduction00:05 Doug's Background and Intelligence Ventures01:07 Under-Emphasized Sectors in AI Healthcare03:10 Future of Healthcare Market Leaders04:24 Impact of ChatGPT and AI in Healthcare05:42 Importance of Proprietary Data07:07 Successful Data Collection Strategies08:00 Building Partnerships in Healthcare09:20 Doug's Personal Journey and Failures10:56 Age and Experience in Venture Capital12:32 Building a VC Firm Like a Startup14:27 Future Vision for Intelligence Ventures16:15 Excitement About Quantum Computing18:57 Separating Signal from Noise in Startups21:17 Strategies for Founders Approaching Investors23:02 Building Relationships with Key Stakeholders24:29 Importance of Founder Qualities26:38 Intelligence Ventures' Value Add28:30 Pre-Seed and Seed Stage Investing30:06 LP Strategy and Community Building32:42 Challenges in Starting a VC Firm34:22 Ranking Importance: Founder, Market, Product, Price35:26 Managing Data Rooms for Founders36:44 Future Vision for Intelligence Ventures38:02 Challenges in Starting a VC Firm39:52 Tips for Founders on LinkedIn43:34 Raising Capital Through LinkedIn Campaigns45:19 Venture Scale Disruption in Healthcare47:37 Advice for Founders Selling to Healthcare Systems48:56 Intelligence Ventures' Portfolio Strategy50:41 Strategic Partnerships and Support for Portfolio Companies51:37 Opportunities and Challenges in University Startups53:05 Rapid Fire Questions: Pet Peeves and Excitements55:26 Family Life and Venture Life Balance56:42 Florida's Tech EcosystemFollow Doug on LinkedIn:   / douglasnissinoff  Care ShiftCare Shift on LinkedIn: https://www.linkedin.com/company/care...Care Shift on X: https://x.com/careshiftvcCare Shift Website: https://careshift.vc/Follow Sathvik Bilakanti: www.linkedin.com/in/sathvik-bilakanti-8b5344169Sathvik on X: https://x.com/SathvikBil

Most of us take clear vision for granted until access to eye care becomes a barrier. Matthias Hofmann shares how Eyebot is revolutionizing vision testing with kiosks that are accessible, affordable, and scalable. Imagine a world where 25 percent of US counties lack an eye doctor, yet millions still need glasses they cannot afford or simply cannot reach. Eyebot aims to change that.In this episode, you will discover the surprising scale of global and domestic eye health gaps, why traditional clinics cannot keep pace with demand, and how automation and AI are transforming the way care is delivered. Matthias breaks down the science behind Eyebot platform, an infrared powered system that is as simple as standing in front of a balloon and receiving instant prescriptions reviewed by licensed doctors. We explore early lessons from deploying in retail locations, how to navigate hardware and software development in regulated environments, and the importance of designing inclusive user interfaces that work for anyone, anywhere.You will also hear the bold vision of making eye care as common and accessible as buying shoes, delivered in grocery stores, airports, and beyond. Matthias explains how their triaging technology not only provides prescriptions but also screens for systemic eye diseases, creating opportunities for early intervention that could save lives.This episode is essential for founders, healthcare innovators, and anyone interested in how automation can democratize health services globally. The stakes are high, but the opportunity to create lasting impact is even greater. If you believe technology should serve everyone equally and that scaling healthcare solutions matters, this conversation will inspire you to see the future of eye care and health differently.Timestamps0:09 - Introduction and Guest Introduction0:55 - The Vision Care Problem4:00 - Eyebot's Mission and Innovation7:43 - Early Challenges and Lessons12:12 - Marketing and Business Model17:10 - Future of Vision Care19:21 - Advice for Founders27:35 - Business Insights and Strategies31:08 - Team Growth and Hiring Practices33:40 - Future of Eye Care35:14 - Competition and Market Position37:12 - Potential of Kiosks in Healthcare39:19 - Balancing Hardware and Software42:34 - Customer Feedback and Product Development44:46 - Investment and Growth48:13 - Personal Reflections, Closing, and Quick RapidFire51:17 - Final Thoughts and FarewellSocials for Care ShiftCare Shift LinkedIn: https://www.linkedin.com/company/care-shift/?viewAsMember=trueCare Shift on X: https://x.com/careshiftvcCare Shift Website: https://careshift.vc/Socials for EyebotEyebot Website: https://www.eyebot.co/Matthias' LinkedIn: https://www.linkedin.com/in/mchofmann/

Most breakthroughs in healthcare occur when founders move beyond selling isolated products and begin deeply understanding what truly drives customer incentives, then design solutions around those realities. Othman Laraki, co-founder of Color Health, shares the counterintuitive strategies behind transforming billions of dollars in public health spending into scalable, personalized care.In this episode, Othman explains how Color navigates complex healthcare stakeholder dynamics, from government agencies to leading cancer centers, by focusing on what organizations genuinely need rather than what they claim to want. He offers behind-the-scenes insights into major partnerships with UC health systems, Memorial Sloan Kettering, the NIH, and large employers, illustrating how significant wins are driven by credibility, scientific rigor, and a clear understanding of incentives.Listeners will learn practical tactics for breaking into slow-moving enterprise markets, including why avoiding pilots in favor of partnerships with defined growth paths often leads to better outcomes. Othman also unpacks the idea of the “product behind the product,” showing how clinical services layered around genetic testing unlock faster scale, deeper impact, and more sustainable revenue. He emphasizes simplifying healthcare pricing and operations to eliminate misaligned incentives that hinder innovation.The conversation also explores why healthcare remains constrained by a broken payment system. Othman examines structural flaws in fee-for-service and insurance models and explains how these incentives block transformative solutions such as at-home monitoring and AI-driven care. He argues that building for long-term outcomes and aligning with true buyers, including employers, unions, and government entities, is essential to creating durable healthcare businesses.This episode is ideal for founders, healthcare operators, and investors seeking to understand how to scale health technology, particularly in cancer prevention and population health. For anyone frustrated by selling solutions that fail to match real market needs, this discussion offers a clear framework for achieving both meaningful impact and sustainable growth.Othman Laraki is the co-founder and CEO of Color Health, a company advancing population health through proactive screening, genomics, and large-scale care infrastructure. Previously, he co-founded Mixer, which was acquired by Twitter, and brings deep experience navigating healthcare regulation while driving innovation in digital health. Currently, Color is worth over $4B.Whether you are grappling with enterprise sales, product-market fit in healthcare, or the challenge of aligning incentives for long-term impact, this conversation delivers practical insights and candid perspectives that cut through the noise.TimestampsIntroduction and Guest Welcome - 0:09Color Health's Achievements - 0:23Strategic Partnerships and Major Deals - 0:52Challenges in Healthcare Entrepreneurship - 1:21Scientific Credibility and Holistic Services - 6:42Navigating Healthcare Market Dynamics - 12:35AI's Role in Healthcare - 16:55Consumer Mindset and Healthcare Access - 20:51Future of Cancer Care and Innovation - 39:02 Conclusion and Key Takeaways - 52:06Socials for Color Health & Othman LarakiColor Health Website: https://www.color.com/Color Health LinkedIn: https://www.linkedin.com/company/colo...Othman's LinkedIn:   / othmanlaraki  Othman's X: https://x.com/othman

Most investors overlook how AI can revolutionize women’s health — Alice Zheng reveals the untapped strategies that will shape the future of reproductive, maternal, and menopausal care. If you’re a founder in this space or an investor looking to capitalize on overlooked opportunities, this episode is your blueprint for the next wave of innovation.Alice Zheng, a partner at Foreground Capital, shares her expertise on how AI is moving from back-office automation to frontline patient engagement in women’s health. She breaks down the essential sectors VC firms are missing right now, from hormonal health to longevity, and explains how startups can leverage AI for more precise diagnostics, drug discovery, and personalized care. Discover the emerging trends, investment strategies, and regulatory insights that will be crucial over the next five years.You’ll learn:The key AI-driven opportunities in women’s health that are still underfunded and underservedHow the landscape of exits is evolving — strategic acquisitions are replacing traditional IPOsThe critical gaps in areas like endometriosis, PCOS, pelvic floor issues, and recurrent UTIs that hold 10x return potentialThe importance of navigating policy and regulation early for startup successStrategies for founders to attract funding and collaborate with major corporations like Apple and incumbentsThe future of payer integration, value-based payments, and AI’s role in clinical decision supportWhether you're building the future of reproductive tech or engineering smarter health systems, the insights in this conversation will guide your strategy and inspire next-level thinking.TimestampsThe AI wave in women's health - 00:00:24Relevance with women's health - 00:01:12Gaps in women's health - 00:05:24Hormonal health and longevity - 00:07:07Venture capital and women's health - 00:10:33Women in venture capital - 00:14:17LPs and venture capital trends - 00:19:29Sourcing framework for investments - 00:23:13Market readiness for venture scale - 00:28:14AI in healthcare - 00:30:14Payor strategies and challenges - 00:31:17Adoption of AI by payors - 00:34:03Foreground's mission and future - 00:39:22Clinical red flags in pitch decks - 00:40:32Investing in overlooked health problems - 00:41:51Importance of health policy for startups - 00:44:01Benefits of partnering with Foreground - 00:45:08Balancing work and family life - 00:49:37Socials for Alice ZhengLinkedIn: https://www.linkedin.com/in/alicexzheng/More about Foreground Capital: https://foreground.vc/Socials for Stahvik BilakantiX: https://x.com/SathvikBilLinkedIn: https://www.linkedin.com/in/sathvik-bilakanti-8b5344169/?skipRedirect=true

In this episode, Matt Faustman shares his journey in healthcare innovation, focusing on the transformative role of AI in streamlining administrative processes. He discusses the challenges faced by healthcare startups, the importance of addressing back-office inefficiencies, and the impact of strategic partnerships in scaling operations.Matt also offers insights into the future of healthcare, emphasizing the potential of autonomous AI to revolutionize the industry and improve patient care.He explains:Why AI is essential for healthcare transformationThe biggest hurdles in healthcare startup growthHow strategic partnerships can drive successThe significance of mission-driven innovationTimestamps0:00 Introduction & Background5:30 Honey Health's Back Office Frustrations10:15 AI Agents In Healthcare13:15 Impact of New AI Technologies17:50 Horizontal vs. Vertical Growth20:30 Building Networks in Healthcare24:30 Future Milestones for Honesy Health27:20 Challenges & Advantages in healthcare32:00 Advice for Founders35:40 Working with payers40:12 Challenges of Entrepreneurship44:09 The Importance of a Strong Funding TeamSocials for Matt FaustmanX: https://x.com/MatthewFaustmanLinkedIn: https://www.linkedin.com/in/matthewfaustman/Socials for Stahvik BilakantiX: https://x.com/SathvikBilLinkedIn: https://www.linkedin.com/in/sathvik-bilakanti-8b5344169/

Amit Garg is the Co-Founder and General Partner at Tau Ventures, an AI-first early-stage investment firm with over $90 million in AUM, focusing on healthcare, enterprise, and automation.In this episode, Amit shares insights from his journey in venture capital, discussing the challenges and opportunities in healthcare innovation. He delves into the role of AI in transforming healthcare, the importance of strategic partnerships, and the lessons learned from investing in groundbreaking companies like Automize AI and Assort Health.Amit also offers valuable advice for founders navigating the complexities of healthcare startups, emphasizing the need for a strong mission and the power of AI to drive efficiency and impact.He explains:Why AI is crucial for the future of healthcareThe biggest challenges in scaling healthcare startupsHow to leverage partnerships for growthThe importance of mission-driven entrepreneurshipTimestamps:00:10 Introduction to Care Shift and Guest Introduction00:51 Navigating the Healthcare Landscape02:21 AI Adoption in Healthcare04:58 Reducing Grunt Work in Healthcare06:06 Siftwell and Analytics for Payers07:29 Framework for Engaging with Payers37:44 Boring Niches with Potential38:18 Healthcare's Rapid AI Adoption39:38 Rapid Fire QuestionsFollow Amit Gargx.com/amitgargLinkedIn: https://www.linkedin.com/in/amgarg/

Kristian Ranta is the Founder and CEO of Meru Health, a digital mental health company redefining how depression and anxiety are treated through a whole-body, whole-mind approach.In this episode, Kristian opens up about losing his brother to suicide, the failures of traditional mental health care, and what founders get wrong when building regulated healthtech companies. We break down how mental health products actually scale, how regulation should be planned from day one, and what it takes to build something that truly helps patients.Kristian also shares hard-earned advice for founders navigating digital health, reimbursement, and clinical credibility, along with his perspective on where mental health care is heading next.He explains:Why most mental health solutions fail patients despite good intentionsThe biggest mistakes founders make when planning regulatory pathwaysWhy treating the mind and body separately doesn’t workHow personal loss shaped Meru Health’s missionWhat founders must get right to build real clinical impactTimestamps:00:00 Intro and guest welcome01:18 Planning the right regulatory pathway11:22 Losing a brother and the motivation behind Meru Health15:00 The real challenges in mental health care today22:22 Integrating whole-body and whole-mind wellness30:00 Advice for founders building in digital health35:00 Final thoughts and closing remarksFollow KristianLinkedIn: https://www.linkedin.com/in/kristian-ranta/X: https://x.com/ihqkristian?s=20Care ShiftX: https://x.com/careshift1LinkedIn: https://www.linkedin.com/company/care-shift/homeSathvik Bilakantihttps://beacons.ai/sathvikbilakanti